M Hakama

709 total citations
19 papers, 546 citations indexed

About

M Hakama is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, M Hakama has authored 19 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in M Hakama's work include Cancer Risks and Factors (2 papers), Global Cancer Incidence and Screening (2 papers) and Cervical Cancer and HPV Research (2 papers). M Hakama is often cited by papers focused on Cancer Risks and Factors (2 papers), Global Cancer Incidence and Screening (2 papers) and Cervical Cancer and HPV Research (2 papers). M Hakama collaborates with scholars based in Finland and Sweden. M Hakama's co-authors include Nea Malila, Maarit K. Leinonen, Pirkka‐Pekka Laurila, Ahti Anttila, Jussi Tarkkanen, Anssi Auvinen, ­Eero Pukkala, Pentti Nieminen, Laura Kotaniemi‐Talonen and Jorma Isola and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, BMJ and British Journal of Cancer.

In The Last Decade

M Hakama

19 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Hakama Finland 10 291 228 153 101 96 19 546
Mary Corkill United States 12 164 0.6× 362 1.6× 157 1.0× 87 0.9× 97 1.0× 17 674
LA Brinton United States 7 306 1.1× 241 1.1× 65 0.4× 60 0.6× 88 0.9× 13 692
Emerson Day United States 11 214 0.7× 244 1.1× 119 0.8× 91 0.9× 89 0.9× 22 654
Sihem Hmissa Tunisia 14 202 0.7× 147 0.6× 134 0.9× 101 1.0× 100 1.0× 66 566
Anca Florea Canada 12 100 0.3× 185 0.8× 133 0.9× 49 0.5× 90 0.9× 17 450
Janie Roberson United States 16 168 0.6× 375 1.6× 261 1.7× 66 0.7× 22 0.2× 33 620
Grace McKee United Kingdom 12 123 0.4× 122 0.5× 98 0.6× 47 0.5× 189 2.0× 30 477
Nadereh Behtash Iran 18 305 1.0× 355 1.6× 244 1.6× 110 1.1× 51 0.5× 77 1.0k
Axel Reinecke‐Lüthge Germany 12 175 0.6× 321 1.4× 260 1.7× 18 0.2× 22 0.2× 17 537
Alireza Mousavi-Jarrahi Iran 8 236 0.8× 148 0.6× 170 1.1× 131 1.3× 44 0.5× 10 513

Countries citing papers authored by M Hakama

Since Specialization
Citations

This map shows the geographic impact of M Hakama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Hakama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Hakama more than expected).

Fields of papers citing papers by M Hakama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Hakama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Hakama. The network helps show where M Hakama may publish in the future.

Co-authorship network of co-authors of M Hakama

This figure shows the co-authorship network connecting the top 25 collaborators of M Hakama. A scholar is included among the top collaborators of M Hakama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Hakama. M Hakama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kilpeläinen, Tuomas P., Teuvo L.J. Tammela, Nea Malila, et al.. (2013). Prostate Cancer Mortality in the Finnish Randomized Screening Trial. JNCI Journal of the National Cancer Institute. 105(10). 719–725. 83 indexed citations
2.
Leinonen, Maarit K., Pekka Nieminen, Stefan Lönnberg, et al.. (2012). Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland. BMJ. 345(nov29 3). e7789–e7789. 77 indexed citations
3.
Anttila, Ahti, Laura Kotaniemi‐Talonen, Maarit K. Leinonen, et al.. (2010). Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ. 340(apr27 1). c1804–c1804. 118 indexed citations
4.
Cardis, Elisabeth, Martine Vrijheid, Maria Blettner, et al.. (2005). Cancer risk following low doses of ionizing radiation – a retrospective cohort study in 15 countries. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 12 indexed citations
5.
Knekt, Paul, M Hakama, Riikka Järvinen, ­Eero Pukkala, & Markku Heliövaara. (1998). Smoking and risk of colorectal cancer. British Journal of Cancer. 78(1). 136–139. 50 indexed citations
6.
Hakama, M. (1996). Chemoprevention in cancer control. 18 indexed citations
7.
Hakama, M, Ulf‐Håkan Stenman, Paul Knekt, et al.. (1996). CA 125 as a Screening Test for Ovarian Cancer. Journal of Medical Screening. 3(1). 40–42. 9 indexed citations
8.
Holli, K, J Isola, & M Hakama. (1995). Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient - fact or fallacy. British Journal of Cancer. 71(1). 124–127. 20 indexed citations
9.
Auvinen, Anssi, et al.. (1994). Overexpression of p53 and long-term survival in colon carcinoma. British Journal of Cancer. 70(2). 293–296. 71 indexed citations
10.
Hakama, M. (1993). Potential contribution of screening to cancer mortality reduction.. PubMed. 17(4-5). 513–20. 16 indexed citations
11.
Aaran, R.-K., et al.. (1988). Carcinoembryonic antigen levels in sera drawn 1 to 12 years before diagnosis of cervical malignancy.. PubMed. 13(1). 9–12. 1 indexed citations
12.
Hakama, M. (1986). Scientific basis of screening in early detection.. PubMed. 9(1-2). 139–43. 1 indexed citations
13.
Teppo, L, M Hakama, Timo Hakulinen, ­Eero Pukkala, & E Saxén. (1985). Planning and evaluating preventive measures.. PubMed. 27–44. 2 indexed citations
14.
Hakulinen, Timo, et al.. (1981). Survival of cancer patients in Finland in 1953-1974.. PubMed. 13 Suppl 31(7). 1–101. 52 indexed citations
15.
Hakama, M & Hilkka Riihimäki. (1974). End results of breast cancer patients in Finland 1953-1968.. PubMed. 6(2). 115–21. 8 indexed citations
16.
Hakama, M, et al.. (1970). Association of pulmonary tuberculosis and carcinoma of the lung.. PubMed. 51(4). 276–89. 4 indexed citations
17.
Saxén, E, et al.. (1969). Cancer in Finland 1954-1963.. PubMed. 1(4). 291–300. 2 indexed citations
18.
Hakama, M. (1964). [RESULTS OF THE TREATMENT OF BREAST CANCER IN FINLAND, 1953-56].. PubMed. 80. 348–60. 1 indexed citations
19.
Hakama, M. (1963). [EVALUATION OF END RESULTS IN CANCER].. PubMed. 79. 393–400. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026